Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment

NCT ID: NCT01889472

Last Updated: 2017-05-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2017-01-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

CPAP is the most effective treatment of obstructive sleep apnea. Oro-nasal masks may be used in case of mouth leaks but these are associated with higher positive pressure needs and lower compliance to treatment. The present investigation evaluates if CPAP compliance would increase when an oral appliance is used in combination with a nasal mask compared to the use of an oro-nasal mask. Eligible patients are those demonstrating a low compliance when using an oro-nasal mask during CPAP therapy. Patients will be treated with automatic CPAP with one of the above-detailed interfaces for 4 weeks and data will be extracted from the machine report in each condition.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participating subjects will be currently treated by CPAP and low compliance will be assessed according to machine report download demonstrating 3h or less of CPAP usage per night.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obstructive Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

oro-nasal mask

Oro-nasal mask during 1 month of auto CPAP

Group Type ACTIVE_COMPARATOR

Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy

Intervention Type DEVICE

Nasal mask and oral appliance

Nasal mask and oral appliance during 1 month of auto CPAP

Group Type EXPERIMENTAL

Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* normal nasal breathing
* dentition allowing for use of an oral appliance
* absence of mandibular joint pathology
* Patients requiring the use of a facial mask during CAPP titration due to presence of mouth leaks with a nasal/prong interface
* Patients using CPAP less than 3 hours/day as prescribed following CPAP titration

Exclusion Criteria

* Clinical instability
* smoking cessation
* current weight loss strategy
* Marked anatomic abnormalities of upper airway (i.e. macroglossia, tonsils hypertrophy)
* severe cardio-metabolic co-morbidity
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Laval University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Frédéric Sériès

Director IUCPQ sleep laboratory

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frederic Series, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation IUCPQ

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHUM

Montreal, Quebec, Canada

Site Status

IUCPQ

Québec, , Canada

Site Status

AGIRADOM

Grenoble, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada France

References

Explore related publications, articles, or registry entries linked to this study.

Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, Grillet Y, Muir JF, Levy P, Series F, Pepin JL; Scientific Council of The Sleep Registry of the French Federation of Pneumology (OSFP). Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One. 2013 May 15;8(5):e64382. doi: 10.1371/journal.pone.0064382. Print 2013.

Reference Type BACKGROUND
PMID: 23691209 (View on PubMed)

Leotard A, Lesgoirres M, Daabek N, Lebret M, Bailly S, Verain A, Series F, Pepin JL, Borel JC. Adherence to CPAP with a nasal mask combined with mandibular advancement device versus an oronasal mask: a randomized crossover trial. Sleep Breath. 2019 Sep;23(3):885-888. doi: 10.1007/s11325-018-01772-5. Epub 2019 Jan 28.

Reference Type DERIVED
PMID: 30689098 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JDBF-2012

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

MNB-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effectiveness of NOA OATMAD
NCT07111962 NOT_YET_RECRUITING